2/22/2008

The FDA on Thursday announced that it has cleared Wyeth's drug Xyntha as treatment for rare blood-clotting disorder hemophilia A. The drug is indicated for regulating and preventing spontaneous or post-injury bleeding in patients with the disorder.

Full Story:
MarketWatch

Related Summaries